) revealed that Rochester General Health System and its 528-bed
Rochester General Hospital have installed Masimo Patient
SafetyNet system that combines Masimo SET pulse oximetry with
ventilation monitoring and wireless clinician notification. The
Masimo Patient SafetyNet system has been widely used by health
care providers around the world as it is used in ensuring
patient's safety need.
COVIDIEN PLC (COV): Free Stock Analysis
DELCATH SYS INC (DCTH): Free Stock Analysis
ECHO THERAPEUT (ECTE): Free Stock Analysis
MASIMO CORP (MASI): Free Stock Analysis
To read this article on Zacks.com click here.
Masimo Patient SafetyNet is a remote monitoring and clinician
notification system. It measures and monitors patient's
physiological conditions and changes that indicate declining
health status in real-time. When changes occur in the measured
values and indicate deterioration in the patient's condition, the
system automatically sends wireless alerts directly to clinicians
and immediately leads to lifesaving response to the patient's
Further, the Masimo SET provides excellent support to clinicians
to reduce retinopathy of prematurity (ROP) in neonates, screen
newborns for Critical Congenital Heart Disease (CCHD), as well as
perform other functions to improve patient outcome in a
Masimo Patient SafetyNet has been installed in Rochester General
Hospital after an extensive evaluation process that led to
standardization of Masimo SET Measure-Through Motion and Low
Perfusion pulse oximetry in the organization. The performance of
Masimo SET pulse oximetry has been proved by more than 100
independent and objective studies and thousands of clinical
According to the U.S. News & World Report Best Hospitals
Honor Roll, MASI's popular Masimo SET is used in 8 out of the top
10 hospitals to monitor more than 100 million patients annually.
Its accurate measurements, along with increased specificity as
well as sensitivity, help identify fatal breathing difficulties
even during patient motion and low perfusion rate.
Earlier, Masimo had forged an agreement with University
Children's Hospital in Basel, Switzerland. The hospital was the
first pediatric institution in the region to utilize the Masimo
Patient SafetyNet in its general wards.
Masimo Patient SafetyNet faces strong competition from
) Nellcor pulse oximeters. The company has started labeling the
device to promote the usefulness of the product line for CCHD
screening in infants. Moreover, the Food and Drug Administration
(FDA) has approved Covidien's Nellcor Bedside SpO2 Patient
Monitoring System, Bedside Respiratory Patient Monitoring System,
and N-600x Pulse Oximetry Monitoring System for motion tolerance.
Currently, Masimo has a Zacks Rank #3 (Hold). Other medical
instruments stocks that are worth considering include
Delcath Systems, Inc.
Echo Therapeutics, Inc.
). Both of them carry a Zacks Rank #2 (Buy).